과제정보
연구 과제 주관 기관 : 충북대학교
참고문헌
- Ojeda SR, Roth C, Mungenast A, Heger S, Mastronardi C, Parent AS, et al. Neuroendocrine mechanisms controlling female puberty: new approaches, new concepts. Int J Androl 2006;29:256-63 https://doi.org/10.1111/j.1365-2605.2005.00619.x
- Ojeda SR, Heger S. New thoughts on female precocious puberty. J Pediatr Endocrinol Metab 2001;14:245-56
- Fontoura M, Brauner R, Prevot C, Rappaport R. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child 1989;64:1170-6 https://doi.org/10.1136/adc.64.8.1170
- Bassi F, Bartolini O, Neri AS, Gheri RG, Bucciantini S, Cheli D, et al. Precocious puberty: auxological criteria discriminating different forms. J Endocrinol Invest 1994;17:793-7 https://doi.org/10.1007/BF03347778
- Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropinreleasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998;157:363-7 https://doi.org/10.1007/s004310050831
- Shankar RR, Pescovitz OH. Precocious puberty. Adv Endocrinol Metab 1995;6:55-89
- Kappy MS, Ganong CS. Advances in the treatment of precocious puberty. Adv Pediatr 1994;41:223-61
- Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994;45:391-405 https://doi.org/10.1146/annurev.med.45.1.391
- Oostdijk W, Drop SL, Odink RJ, Hummelink R, Partsch CJ, Sippell WG. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group. Acta Paediatr Scand 1991;372 Suppl:39-45
- Ahn SY, Yoo JH, Shin CH, Yang SW. The effects of gonadotropin-releasing hormone agonists on final height and its related factors in patients with true precocious puberty. Korean J Pediatr 2004;47:647-55
- Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone. J Clin Endocrinol Metab 1999;84:449-52 https://doi.org/10.1210/jc.84.2.449
- Tuvemo T, Jonsson B, Gustafsson J, Albertsson-Wikland K, Aronson AS, Hager A, et al. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty. Acta Paediatr 2004;93:1456-62 https://doi.org/10.1080/08035250410021793
- Volta C, Regazzi C, Ndaka J, Vitale R, Bernasconi S. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty. Acta Biomed 2005;76:73-8
- Mul D, Oostdijk W, Waelkens JJ, Drop SL. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone. Clin Endocrinol (Oxf) 2005;63:185-90 https://doi.org/10.1111/j.1365-2265.2005.02323.x
- Carel JC. Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue. Mol Cell Endocrinol 2006;25:226-33
- Kaplowitz P. Clinical characteristics of 104 children referred for evaluation of precocious puberty. J Clin Endocrinol Metab 2004;89:3644-50 https://doi.org/10.1210/jc.2003-031532
- Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Standford. California: Standford univ. press 1993
- Bayley N, Pimenan SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952;40:423-41 https://doi.org/10.1016/S0022-3476(52)80205-7
- Ge X, Conger RD, Elder GH Jr. Coming of age too early: pubertal influences on girls' vulnerability to psychological distress. Child Dev 1996;67:3386-400 https://doi.org/10.2307/1131784
- Sonis WA, Comite F, Blue J, Pescovitz OH, Rahn CW, Hench KD, et al. Behavior problems and social competence in girls with true precocious puberty. J Pediatr 1985;106:156-60 https://doi.org/10.1016/S0022-3476(85)80489-3
- Chillik C, Acosta A. The role of LHRH agonists and antagonists. Reprod Biomed Online 2001;2:120-8 https://doi.org/10.1016/S1472-6483(10)62236-5
- Comite F, Cutler GB Jr, Rivier J, Vale WW, Loriaux DL, Crowley WF Jr. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med 1981;305:1546-50 https://doi.org/10.1056/NEJM198112243052602
- Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropinreleasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998;157:363-7 https://doi.org/10.1007/s004310050831
- Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, et al. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 1999;84:1973-8 https://doi.org/10.1210/jc.84.6.1973
- Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, et al. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996;75:292-7 https://doi.org/10.1136/adc.75.4.292
- Couto-Silva AC, Adan L, Trivin C, Brauner R. Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment. J Pediatr Endocrinol Metab 2002;15:297-305
- Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, et al. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab 1999;84:3575-8 https://doi.org/10.1210/jc.84.10.3575
- Ahn BH, Han HS. Effect of GnRH analogue on predicted adult height in girls with early puberty. Korean J Pediatr 2006;49:552-7 https://doi.org/10.3345/kjp.2006.49.5.552
- Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, et al. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 1985;61:152-9 https://doi.org/10.1210/jcem-61-1-152
- Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, et al. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty. J Clin Endocrinol Metab 1991;72:301-7 https://doi.org/10.1210/jcem-72-2-301
- Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion. J Clin Endocrinol Metab 1991;73:734-8 https://doi.org/10.1210/jcem-73-4-734
- DiMartino-Nardi J, Wu R, Varner R, Wong WL, Saenger P. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein. J Clin Endocrinol Metab 1994;78:664-8 https://doi.org/10.1210/jc.78.3.664
- Juul A, Scheike T, Nielsen CT, Krabbe S, Muller J, Skakkebaek NE. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). J Clin Endocrinol Metab 1995;80:3059-67 https://doi.org/10.1210/jc.80.10.3059
- Leger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment? J Pediatr 2000;137:819-25 https://doi.org/10.1067/mpd.2000.109201
- Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001;86:4711-6 https://doi.org/10.1210/jc.86.10.4711
- Saggese G, Pasquino AM, Bertelloni S, Baroncelli GI, Battini R, Pucarelli I, et al. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr 1995;84:299-304 https://doi.org/10.1111/j.1651-2227.1995.tb13632.x
- Tato L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, et al. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment. Horm Res 1995;44 Suppl 3:49-54 https://doi.org/10.1159/000184674
- Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S. Combined treatment with gonadotropinreleasing hormone analog and growth hormone in central precocious puberty. J Clin Endocrinol Metab 1996;81:948-51 https://doi.org/10.1210/jc.81.3.948
- Seo JY, Yoon IS, Shin CH, Yang SW. The comparison of predicted adult height change and height gain after gonadotropin-releasing hormone agonist and combined growth hormone treatment in girls with idiopathic central precocious puberty. Korean J Pediatr 2006;49:305-11 https://doi.org/10.3345/kjp.2006.49.3.305
- Lee EJ, Han HS. Growth promoting effect of short-term gonadotropin releasing hormone agonist with or without growth hormone in girls with early puberty. Korean J Pediatr 2007;50:198-204 https://doi.org/10.3345/kjp.2007.50.2.198